Quarterly report pursuant to Section 13 or 15(d)

ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.22.2.2
ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Jan. 08, 2022
Jan. 07, 2022
Dec. 31, 2021
Research and development costs $ 459,847 $ 566,655 $ 992,491 $ 1,052,650      
Advertising and marketing costs $ 29,628 $ 12,438 $ 75,147 $ 70,692      
Increase in authorized shares         $ 1,733,333 $ 1,282,823  
Valuation allowance, percentage     100.00%        
Reverse stock split description     common stock at a ratio between of 1-for-2 and 1-for-3 in connection with our planned listing on Nasdaq. On March 4, 2022 the Board of Directors approved the reverse split ratio of 1-for-3 with the anticipated effective date of the reverse split on or about March 28, 2022. The 1-for-3 reverse stock split went effective with the State of Delaware, FINRA and OTC Markets on April 28, 2022        
Minority Interest [Member]              
Ownership interest, percentage 1.38%   1.38%       1.38%